{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/ovarian-cancer/background-information/risk-factors/","result":{"pageContext":{"chapter":{"id":"c8597bdc-f028-5141-85c3-c6b429bf7d78","slug":"risk-factors","fullItemName":"Risk factors","depth":2,"htmlHeader":"<!-- begin field 0d54aaff-ceb1-4e27-9dec-8cbae74eaad2 --><h2>What are the risk factors?</h2><!-- end field 0d54aaff-ceb1-4e27-9dec-8cbae74eaad2 -->","summary":"","htmlStringContent":"<!-- begin item 32fa6b08-462c-4fed-a41f-98ece21bc381 --><!-- begin field cabf7d8a-d9c6-48f5-9386-5416914fc77b --><ul><li><strong>The risk of ovarian cancer is increased by:</strong><ul><li>Increasing age — the incidence of ovarian cancer increases with age and peaks in the eighth decade [<a class=\"bibliography-reference internal-reference\" href=\"/topics/ovarian-cancer/references/\">BMJ, 2017</a>].</li><li>Genetic factors, including:<ul><li>Gene mutations — BRCA1 and BRCA2 are tumour suppressor genes involved in DNA (deoxyribonucleic acid) repair, and BRCA-related cancers result from mutation or alteration of these genes. The lifetime risk of developing ovarian cancer is estimated at 28–44% for women with the BRCA1 gene mutation, and 27% for women with the BRCA2 gene mutation [<a class=\"bibliography-reference internal-reference\" href=\"/topics/ovarian-cancer/references/\">BMJ, 2017</a>].</li><li>Family history of ovarian cancer — about 3% of ovarian cancer cases occur in women with a family history of ovarian cancer. The risk of ovarian cancer risk is 2.7–3.5 times higher in women whose mother or sister has (or has had) ovarian cancer compared with women with no such family history; the risk may be higher if the affected relative was diagnosed at a younger age [<a class=\"bibliography-reference internal-reference\" href=\"/topics/ovarian-cancer/references/\">Cancer Research UK, 2015</a>]. </li><li>Family history of other cancers — the risk of ovarian cancer is higher in women whose sibling has (or has had) melanoma or stomach, liver, breast, prostate, or connective tissue cancer, or whose parent has (or has had) breast or liver cancer. The risk of ovarian cancer is higher in families with a history of breast cancer compared with the general population, even in the absence of BRCA1 or BRCA2 mutations [<a class=\"bibliography-reference internal-reference\" href=\"/topics/ovarian-cancer/references/\">Cancer Research UK, 2015</a>]. </li></ul></li><li>Reproductive and hormonal factors, including:<ul><li>Conditions that increase the number of ovulatory cycles, such as nulliparity, early menarche, and late menopause — evidence from epidemiological studies shows that the number of ovulatory cycles a woman has in her lifetime is proportional to her risk of developing ovarian cancer [<a class=\"bibliography-reference internal-reference\" href=\"/topics/ovarian-cancer/references/\">Sudhar, 2015</a>].</li><li>In vitro fertilisation (IVF) — the National Institute for Health and Care Excellence (NICE) guideline <em>Fertility: assessment and treatment for people with fertility problems</em> states that the absolute risks of long-term adverse outcomes after IVF is low. However, using the available evidence it is not possible to exclude a small increased risk of borderline ovarian tumours [<a class=\"bibliography-reference internal-reference\" href=\"/topics/ovarian-cancer/references/\">National Collaborating Centre for Women's and Children's Health, 2013</a>].</li><li>Use of hormone replacement therapy (HRT) — there appears to be a small increased risk of ovarian cancer associated with the current use of HRT (both oestrogen-only and combined HRT) for more than five years [<a class=\"bibliography-reference internal-reference\" href=\"/topics/ovarian-cancer/references/\">Cancer Research UK, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/ovarian-cancer/references/\">Collaborative Group on Epidemiological Studies of Ovarian Cancer, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/ovarian-cancer/references/\">Sudhar, 2015</a>]. </li></ul></li><li>Medical conditions, including:<ul><li>Cancer — a history of ovarian, breast, or bowel cancer is associated with an increased risk of ovarian cancer [<a class=\"bibliography-reference internal-reference\" href=\"/topics/ovarian-cancer/references/\">Sudhar, 2015</a>].</li><li>Endometriosis — endometriosis is sometimes found next to endometrioid or clear cell ovarian cancers [<a class=\"bibliography-reference internal-reference\" href=\"/topics/ovarian-cancer/references/\">Kehoe, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/ovarian-cancer/references/\">Jayson, 2014</a>], and evidence has shown an increased incidence of ovarian cancer in women with documented endometriosis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/ovarian-cancer/references/\">Jayson, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/ovarian-cancer/references/\">Cancer Research UK, 2015</a>]. </li></ul></li><li>Lifestyle factors, including [<a class=\"bibliography-reference internal-reference\" href=\"/topics/ovarian-cancer/references/\">Cancer Research UK, 2015</a>]:<ul><li>Tobacco smoking.</li><li>Being overweight and obesity. </li><li>Occupational exposure to asbestos. </li><li>Perineal use of talc-based body powder (although the evidence for this is limited and inconsistent) — the association with ovarian cancer is thought to be due to the mineral talc in talc-containing body powders or due to asbestos traces in some body powders made before the 1970s.</li></ul></li></ul></li><li><strong>The risk of ovarian cancer is reduced by:</strong><ul><li>Conditions that decrease the number of ovulatory cycles, including:<ul><li>An increasing numbers of pregnancies [<a class=\"bibliography-reference internal-reference\" href=\"/topics/ovarian-cancer/references/\">Crawford, 2009a</a>].</li><li>Breastfeeding [<a class=\"bibliography-reference internal-reference\" href=\"/topics/ovarian-cancer/references/\">Colombo et al, 2010</a>].</li><li>The use of the combined oral contraceptive pill [<a class=\"bibliography-reference internal-reference\" href=\"/topics/ovarian-cancer/references/\">Crawford, 2009a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/ovarian-cancer/references/\">Swerdlow et al, 2010</a>].</li><li>Early menopause.</li></ul></li><li>Tubal ligation, and possibly hysterectomy [<a class=\"bibliography-reference internal-reference\" href=\"/topics/ovarian-cancer/references/\">Colombo et al, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/ovarian-cancer/references/\">Swerdlow et al, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/ovarian-cancer/references/\">Jayson, 2014</a>].</li><li>Prophylactic oophorectomy [<a class=\"bibliography-reference internal-reference\" href=\"/topics/ovarian-cancer/references/\">Colombo et al, 2010</a>].</li></ul></li></ul><!-- end field cabf7d8a-d9c6-48f5-9386-5416914fc77b --><!-- end item 32fa6b08-462c-4fed-a41f-98ece21bc381 -->","topic":{"id":"e76d1533-c4e4-5615-b47d-b9a78e802a8c","topicId":"2b5f9995-52a6-4997-b11b-4dd86f5b4cac","topicName":"Ovarian cancer","slug":"ovarian-cancer","lastRevised":"Last revised in July 2018","chapters":[{"id":"00f52bf3-2854-5c26-896d-9e19a7a50ffa","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"1978d14c-1832-5012-aad2-ae688f64a4f0","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"39ed13eb-bf02-5897-9546-f63bb13e1312","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"b6205ec5-8fed-5fa0-9459-17c9ed9797a4","slug":"changes","fullItemName":"Changes"},{"id":"dff67d8b-2740-5711-b49a-d03a83243ab3","slug":"update","fullItemName":"Update"}]},{"id":"4d027c28-c2b3-5578-8eab-c2029d5b3347","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"f40d2697-554a-5249-abb4-6247e9db5eca","slug":"goals","fullItemName":"Goals"},{"id":"6b3fba32-56cd-5102-879a-64cb859b80ef","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"8e5550d6-e4d8-54a5-8046-0542cdf4be38","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"c7811d8a-c44d-5470-8e72-e0a8ff4d2d61","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"816a9080-6571-5a58-bfe1-04411127e3d2","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"4afe1f86-c28e-51bf-8c7f-39373606165d","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"39f05ca6-5cf0-5e67-af39-03983de815d1","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"03b4909c-fc38-5af3-848f-1df54131e0c5","slug":"definition","fullItemName":"Definition"},{"id":"83553e71-1f1a-543b-be50-09b4c7b8c224","slug":"incidence","fullItemName":"Incidence"},{"id":"c8597bdc-f028-5141-85c3-c6b429bf7d78","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"e5f859f0-168b-5395-a133-af2778a0ef84","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"4d5f7685-3efd-5198-90e1-d8cb8f470a28","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"26a540a4-c12b-5ae8-b3de-eb2d3472a824","slug":"when-to-suspect-ovarian-cancer","fullItemName":"When to suspect ovarian cancer"},{"id":"d7d39f7a-9f30-588c-9589-b8c8b5a76729","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"d02788d8-8b2d-5672-8eca-dfcc643a2055","fullItemName":"Management","slug":"management","subChapters":[{"id":"e47609d5-133b-5929-ad56-44ab30116871","slug":"managing-a-woman-with-suspected-ovarian-cancer","fullItemName":"Scenario: Managing a woman with suspected ovarian cancer"}]},{"id":"99dcdee4-9931-5ef8-a3d8-d86417646b02","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"9b4bd4c6-cb71-5783-8529-7346c25fc30f","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"11ba9663-4a8b-516e-a825-1f8d766c7041","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"ec67bf69-9ccc-5c53-81da-f2c0713d4527","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"bcf5ab6b-23af-5b9a-bbcd-22d0002e20cf","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"ac95df2b-f68f-5f64-bb51-88ff094f74b8","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"23bfe348-903c-5728-b9b9-71e7975e7e53","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"faaa4aff-4567-544b-af9e-b7dc24fae5df","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"39f05ca6-5cf0-5e67-af39-03983de815d1","slug":"background-information","fullItemName":"Background information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}